3D Communications and SolemEU have created a joint venture to help pharmaceutical, biotechnology and medical device companies develop and successfully communicate their value proposition to key stakeholders, such as payers, physicians, patients and policymakers.
The joint venture expands 3D’s “Market Access and Value Communications” services throughout Europe. It leverages SolemEU’s proven international market access track record and its network of senior executives experienced in developing and executing pricing, reimbursement and market access strategies.
The process moves beyond traditional market access approaches. It uses a 3D method that assesses how the complex stakeholder environment, local market realities and the evolution of treatment interact and influence a product’s value proposition.